SRT: Innovating a New Treatment for Skin Cancer Treatment
Innovating upon a tried-and-true technology, an updated device is available for dermatologists to use to fight skin cancer. BY JEFFREY FROMOWITZ, MD As a dermatologist in practice in Boca Raton, FL, I am upon this tried-and-true technology, created an updated at the front lines of the ever-growing skin cancer epidemic. As such, I am always […]
Sensus Healthcare Offers Non-Surgical Option for Non-Melanoma Skin Cancer
CEO Joseph Sardano says skin cancer is often catching up with people earlier in life than it used to. Sensus Healthcare Inc. (SRTS) is marketing devices that offer some non-melanoma skin cancer (NMSC) patients an alternative to traditional Mohs surgery. Boca Raton, Fla.-based Sensus’ superficial radiation therapy (SRT) technology allows doctors to apply radiation skin-deep, […]
Medical device company taps into 1.4 billion-person market with deal in China
Boca Raton medical device maker Sensus Healthcare has been cleared to expand operations in China, bringing its skin-treatment technology to a country with more than 1.4 billion people. Sensus Healthcare (NASDAQ: SRTS) has made a name for itself in the medical community with the SRT-100, a device sold to dermatology practices which non-invasively treats skin conditions, including keloids, […]
Skin cancer treatment technology provides alternative to surgery for skin cancer patients
Skin cancer generally appears within the first two to three millimeters of the surface of the skin. “The traditional way to treat skin cancer is surgery,” said Dr. Jeffrey Brackeen, with the Skin Cancer Institute of Lubbock. The SRT-100, he said, provides a non-invasive treatment option for skin cancer patients. The tool is relatively new […]
My New Favorite Thing: SUPERFICIAL RADIATION THERAPY
With Sensus’ superficial radiation therapy (SRT), we may be entering uncharted waters where keloid recurrence after surgery and SRT leads to no, or a very low, incidence of keloid recurrence. With this, we will change the paradigm in the treatment of keloids. The Sensus SRT-100 is a superficial radiation device that has FDA clearance—the first […]
This Boca Raton company was named South Florida’s most ‘disruptive’
The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017. Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as non-melanoma skin cancers. Its best-known device is the SRT-100 Vision, a device sold to dermatologists nationwide. The Technology Leader of […]
The Doctor’s Ultimate Wish List for Ending the Skin Cancer Epidemic
Despite tireless public awareness campaigns aimed at encouraging sun-safe behaviors and advances in skin cancer detection, the rates of this all-too-common, but highly preventable cancer continue to rise. Nearly 9,500 Americans are diagnosed with skin cancer each day, and fully one in five Americans will develop skin cancer in their lifetime, according to the American […]
Dr. David J Goldberg Presents at AAD 2017
Superficial radiation advances as option for NMSC treatment David J. Goldberg, MD, JD, examined the genesis of the evolution of superficial radiation therapy (SRT) during “New and Emerging Therapies for Non-Melanoma Skin Cancers,” part of “New Emerging Therapies” (S022). Dr. Goldberg is a dermatologic surgeon at Skin Laser and Surgery Specialists of New York/New Jersey. […]
Superficial radiation therapy offers an effective alternative to Mohs surgery
Dr. David Goldberg spoke at the 2017 South Beach Symposium conference on how SRT technology has rapidly advanced in the past 30 years and how SRT is an effective way to eradicate tumors while maintaining or improving patients’ quality of life. Below is an excerpt from the article by Healio.com covering this presentation: MIAMI — Superficial […]
Sensus Healthcare CEO Shares A Look Into Skin Cancer Treatment
Sensus Healthcare Inc (NASDAQ: SRTS) (NASDAQ: SRTSU) is micro-cap manufacturer of superficial radiation therapy (SRT) devices for the treatment of skin cancer and keloids, which went public on the Nasdaq exchange in June. Benzinga recently had the chance to chat with the company’s CEO Joseph C. Sardano, who shared some insight into the company and […]
